An unsolicited med spa offer: how to decide whether it is fair

An unsolicited med spa offer is an opening proposal from one buyer, not proof of your business’s market value. Verify who is buying, what earnings and assets support the price, how payment works, and which conditions remain. Protect information, compare credible alternatives, and review exclusivity before giving one party control of your sale process.

What should you do when the first email or call arrives?

Acknowledge the approach without accepting a valuation or promising exclusivity. Ask for the buyer’s legal name, ownership, acquisition criteria, relevant experience, and intended role in the practice. Determine whether the caller is the principal, a broker, a searcher, or an intermediary representing a platform.

Keep an initial record of the conversation, including the assumptions behind any quoted range. A buyer who has not seen earnings may be offering an exploratory indication rather than a firm price. Avoid repeating that indication to staff as though a transaction has been agreed.

A neutral response preserves options: explain that you would consider a confidential discussion after understanding the buyer and process. You do not need to send financial statements, provider names, or patient data merely because the approach sounds sophisticated. Set a disclosure sequence and use qualified advice before signing binding terms.

How can you determine whether the buyer can execute?

Ask who supplies equity, whether financing is required, who approves the transaction, and what evidence of funds can be provided at the appropriate stage. An acquisition thesis or sponsor logo is not the same as committed capital. Confirm the identity of the party expected to sign and pay.

SBA’s description of 7(a) loans includes ownership changes but also repayment and eligibility requirements. If a buyer relies on acquisition financing, request its lender path and conditions rather than treating a preliminary lender conversation as an approval. Keep financing uncertainty visible in the comparison.

Request references from completed acquisitions and ask factual questions about diligence, communication, payment, integration, and retained seller obligations. Respect confidentiality while verifying claims independently. A buyer may be credible yet unsuitable for your desired timing, clinical role, or level of continuing involvement.

Which written terms reveal what the offer means?

Request an indication that defines the acquired business, valuation basis, consideration components, debt and cash treatment, working-capital assumptions, required seller role, and key contingencies. Ask whether the buyer is proposing an asset or equity transaction and what professional-entity arrangements are contemplated.

Keep the answers with the proposal. A large number attached to undefined terms is less decision-ready than a smaller but fully explained offer. Ask the buyer to distinguish nonbinding pricing discussion from provisions it expects to be enforceable.

How do you test the earnings behind the price?

Reconcile the buyer’s earnings figure to your own records. Check whether owner compensation, clinical labor, related-party rent, product costs, memberships, and unusual expenses are handled consistently. A multiple applied to an unsupported earnings number can create an attractive headline that disappears during diligence.

Show the operation the buyer expects after closing. If you continue injecting or managing, state the compensation and duration. If you leave, include realistic replacement resources. Do not assume that compensation for future work is part of the price paid for past business value.

Ask which buyer synergies are included. A platform may expect purchasing or administrative savings, but they need implementation and may not belong entirely to the seller. Separate existing earnings from projected improvements. This allows a reasoned negotiation without claiming the buyer must pay for every possible future benefit.

What is the difference between price and closing proceeds?

Compare cash, seller financing, rollover, earnout, escrow, and liabilities on one worksheet. Include debt payoff and transaction expenses. Mark the payment dates and conditions. A proposal described as all cash may still leave a portion withheld or subject to post-closing adjustment.

IRS guidance on selling a business explains that the assets and transaction structure affect tax treatment. Ask your CPA to estimate the after-tax result using the proposed allocation and payment timing. The example above is arithmetic for comparing components, not an estimate of any owner’s tax or value.

How much information should you release?

Begin with a limited, anonymized overview and move to detailed business records after buyer qualification and a suitable confidentiality agreement. Restrict access by stage, watermark sensitive files where useful, and maintain a disclosure log. Agree when the buyer may contact employees, landlords, suppliers, or competitors.

HHS’s covered-entity guidance explains that HIPAA status depends on defined conditions; a cash-pay description does not settle every privacy question. Have counsel determine the legal basis and safeguards for any identifiable health information. Use aggregated commercial reporting for early valuation analysis wherever feasible.

Do not allow speed to erase privacy controls. If a buyer needs provider-level production, anonymized identifiers may answer the commercial question initially. If more detailed review becomes necessary, define recipients, access purpose, retention, and deletion procedures. A confidentiality agreement is one protection, not a universal authorization to disclose every record.

When does exclusivity help, and when does it create leverage?

Exclusivity can justify a buyer’s investment in diligence, but it also limits your ability to test alternatives. Review its duration, milestones, extension rights, termination conditions, and interaction with the seller’s ongoing obligations. Counsel should identify what is binding in the letter of intent.

Before granting it, confirm that the price assumptions, financing path, requested records, structural plan, and seller role are sufficiently clear. Ask for a concrete work plan with responsible parties. A buyer that cannot explain how it will reach approval may consume an exclusive period without making measurable progress.

Keep your own preparation current during the period. Maintain operating performance, resolve information requests promptly, and record scope changes. If a material issue emerges, assess it with advisors. Exclusivity should support an informed decision, rather than become a reason to accept new terms because too much time has already passed.

How can you compare alternatives without disrupting the business?

Ask an advisor to assess the offer against a realistic buyer universe and relevant completed transactions. Alternatives include a controlled broader process, a later sale after preparation, an employee or partner solution, or continuing ownership. They are options to evaluate, not threats to manufacture during negotiation.

1. Verify the buyer and capital path.
2. Define the business and accepted earnings.
3. Map all payment components and seller duties.
4. Protect disclosure and review exclusivity.
5. Compare executable alternatives against your objectives.
6. Document the reason to proceed, counter, pause, or decline.

Use the seller resource hub, owner valuation estimate, and private-equity pricing guide to structure the review. A fair offer should make sense after the assumptions are exposed. You should be able to explain why it fits your priorities without relying on the excitement of being approached.

Keep personal objectives in the written comparison. If your priority is leaving clinical work within six months, an offer requiring several years of production may be a poor fit despite attractive nominal consideration. If your priority is participating in future growth, investigate the retained investment and operating role. Clarifying these choices early avoids spending the entire negotiation optimizing a number that does not solve the owner’s actual problem. A sound decision weighs execution and life plans alongside price.

Educational analysis prepared with AI-assisted research for The Med Spa Broker. “Last reviewed” records the source and editorial check date; it does not imply review by an attorney, clinician, or independent appraiser. Read our editorial standards.